scholarly journals TECHNOLOGY TRANSFER OF PUBLIC RESEARCH RESULTS (INCDMTM) TO THE PRIVATE SECTOR

2006 ◽  
Vol 20 (2) ◽  
pp. 123-133 ◽  
Author(s):  
Santanu Roy

Managing R&D and the innovation process is closely linked with technology transfer and the commercialization of research results. This is especially so in the context of publicly-funded R&D laboratory systems in developing countries, such as India's Council of Scientific and Industrial Research (CSIR). Inefficiencies in the transfer process and a lack of orientation towards the commercialization of scientific research results are predominantly responsible for ineffective public research. Against this background, the paper puts forward an argument for the adoption of a networking strategy or consortium-style operation by the various actors in the technological innovation process. To this end, the author presents case studies of specific technology development and commercialization efforts undertaken in different laboratories functioning under the CSIR. The lessons drawn from the case studies and the key elements that have led to the success of these initiatives are highlighted.


2020 ◽  
Vol 7 (1) ◽  
pp. 25-32
Author(s):  
Krystian Gurba

Organizations managing technology transfer from universities to the private sector, although born in Poland with a significant delay compared to Western European countries, are currently important actors in the Polish innovation system. The article summarizes the process of shaping the role and models of the functioning of these organizations. It discusses the status and functions of technology transfer centers and the institutional environment of academic technology transfer in Poland: legal framework, support programs, and partner organizations. Furthermore, it highlights the importance of cooperation networks in technology transfer and draws attention to specific initiatives focused on technology transfer in the biotechnology and pharmacy sectors.


2020 ◽  
pp. 1386-1402
Author(s):  
Pierre-Jean Barlatier ◽  
Eleni Giannopoulou ◽  
Julien Pénin

In the era of open innovation, companies that want to innovate can no more remain isolated, they have to interact and collaborate with diverse actors of the innovation process. The rise of open innovation practices resulted in an increase of intermediaries for innovation. This chapter aims to better understand why innovative companies use the services of such intermediaries. Two distinct types of open innovation intermediaries have been identified, whose roles are significantly different; while the first type help companies to reduce transaction costs related to open innovation, the second type may be implicated directly in the creation, transfer and diffusion of knowledge. This chapter illustrates both roles in the case of public research valorization and distinguish clearly “Technology Transfer Organizations” (TTOs), whose role is to reduce transaction costs related to technology transfer from “Research and Technology Organizations” (RTOs) that are actively involved in knowledge creation and transfer processes.


Author(s):  
Ziyuan Sun ◽  
Man Wang ◽  
Weiwei Zhang ◽  
Yanli Li ◽  
Dan Wang ◽  
...  

University–industry technology transfer (UITT) plays an important role in the construction of the national pharmaceutical innovation system. The speculations of a faculty inventor may hinder the successful transfer of pharmaceutical research results. This paper divides the specific process of the transformation of pharmaceutical research results into two parts: (1) an evolutionary game between faculty inventors and universities; and (2) a Stackelberg game between faculty inventors and pharmaceutical companies. Further, we carry out numerical simulations to analyze the impact of transformation success rate, income distribution coefficient, and a faculty inventor’s future working years on the transformation of pharmaceutical research results. The findings indicated that whether a combination of action strategies of faculty inventors and universities can evolve to the optimal equilibrium is determined by many factors, such as the technological transaction price of the pharmaceutical company and the reward or the income obtained by the faculty inventor. The transformation success rate and the income distribution coefficient are the key factors that affect the faculty inventor’s will and the behavior of the pharmaceutical company. The conclusions of this paper contribute to the research on how we can improve the success rate of research results and avoid resource waste, and provide a decision-making reference for the management of pharmaceutical research results in universities.


Sign in / Sign up

Export Citation Format

Share Document